首页> 外文期刊>The journal of trauma and acute care surgery >Levothyroxine therapy before brain death declaration increases the number of solid organ donations
【24h】

Levothyroxine therapy before brain death declaration increases the number of solid organ donations

机译:在宣布脑死亡之前使用左甲状腺素治疗增加了实体器官捐赠的数量

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Protocols call for the start of hormonal therapy with levothyroxine after the declaration of brain death. As the hormonal perturbations occur during the process of brain death, the role of the early initiation of levothyroxine therapy (LT) to salvage organs is not well defined. The aim of this study was to evaluate the impact of early LT (before the declaration of brain death) on the number of solid organs procured per donor. METHODS: We performed an 8-year retrospective analysis of all trauma patients who progressed to brain death. Patients who consented for organ donation, received LT, and donated solid organs were included. Patients were dichotomized into two groups: early LT group, patients who received LT before the declaration of brain death, and late LT group, those who received LT after brain death. The two groups were compared for differences in demographics, clinical characteristics, need for vasopressor, and number of solid organ donation. RESULTS: A total of 100 solid organ donors were identified of which, 41% (n=77) donors who received LT therapy were included. LT before the declaration of brain death was initiated in 37 patients compared with 40 patients who had it started after the declaration of brain death. There was no difference in demographics between the two groups except that patients in the early LT group were more likely to be hypotensive on presentation (54% vs. 25%, p = 0.001). Early LT therapy was associated with an increase in solid organ procurement rate (odds ratio, 1.9; 95% confidence interval, 1.4-2.7; p = 0.01). Sixty-seven patients donated a total of 291 solid organs. CONCLUSION: The early use of LT and aggressive blood product resuscitation was associated with a significantly higher number of solid organs donated per donor. Earlier use of LT before the declaration of brain death may be considered in potential organ donors. LEVEL OF EVIDENCE: Therapeutic/care management study, level IV.
机译:背景:方案要求在宣布脑死亡后开始用左甲状腺素进行激素治疗。由于激素的扰动发生在脑死亡的过程中,因此左旋甲状腺素疗法(LT)的早期启动对挽救器官的作用尚不明确。这项研究的目的是评估早期LT(在宣布脑死亡之前)对每个供体获得的实体器官数量的影响。方法:我们对所有进展为脑死亡的创伤患者进行了为期8年的回顾性分析。包括同意器官捐赠,接受LT和捐赠实体器官的患者。将患者分为两类:早期LT组,即在宣布脑死亡前接受LT的患者,和LT晚期组,即在脑死亡后接受LT的患者。比较了两组的人口统计学,临床特征,对升压药的需求以及实体器官捐赠的数量。结果:总共鉴定出100个实体器官供体,其中包括接受LT治疗的41%(n = 77)供体。在宣布脑死亡之前开始进行LT治疗的患者有37例,而在宣布脑死亡之后开始进行LT治疗的患者为40例。两组之间的人口统计学无差异,只是早期LT组患者出现降压的可能性更高(54%vs. 25%,p = 0.001)。早期LT治疗与实体器官获取率增加相关(奇数比为1.9; 95%置信区间为1.4-2.7; p = 0.01)。 67名患者总共捐赠了291个实体器官。结论:早期使用LT和积极的血液制品复苏与每位供体捐赠的实体器官数量明显增加有关。在潜在的器官捐献者中,可以考虑在宣布脑死亡之前更早使用LT。证据级别:治疗/护理管理研究,四级。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号